drugset / Trial / NCT00082069
Invaplex 50 Vaccine Dose-Ranging
Non-randomizedSingle-groupOpen-labelPrevention
Summary
The vaccine is given as a nose spray. Volunteers will receive a 3-dose vaccination with doses spaced two weeks apart. Volunteers will be assigned to a vaccination group based on their order of enrollment with consideration of their availability to complete the necessary vaccinations and follow-up visits.
Timeline
- Start
- 2004-04
- Primary completion
- 2006-11
- Completion
- 2006-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Invaplex 50 | Vaccine | 10 ug | Intranasal |
| Subject | Invaplex 50 | Vaccine | 50 ug | Intranasal |
| Subject | Invaplex 50 | Vaccine | 240 ug | Intranasal |
| Subject | Invaplex 50 | Vaccine | 480 ug | Intranasal |